Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Jordan et al's meta-analysis of antiretroviral drug regimens
supports the continued use of triple therapy for established HIV
infections in adolescent and adult patients.1 While any advance in combating the progression of HIV is clearly welcome, the
potential side effects of treatment need to be known.
Antiretroviral inhibitor use is associated with a range of morphological and metabolic alterations. Altered glucose homeostasis may result in the development of frank diabetes mellitus in up to 7% of patients. Lipid metabolism is also affected and may lead to changes in serum lipid concentrations, which may contribute to an increase in the occurrence of pancreatitis.2
| Table Removed (Available Only in the Full Text) |
Lipodystrophy is a commonly encountered problem associated with
antiretroviral therapy and has been found in 50-60% of patients after
as little as one year of drug treatment. Characteristic morphological
changes include central, intra-abdominal fat deposition, as well as fat
deposition in the dorso-cervical ("buffalo hump") and
Read all Rapid Responses